Jim Simons
GRI

Jim Simons’s GRI Bio GRI Stock Holding History

Jim Simons’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$15K – 3849
2023
Q4 		$15K Buy
+1
New +$41.7K ﹤0.01% 3610
2022
Q3 		– Hold
0
– -$50K – 4162
2022
Q2 		– Hold
0
– – – 3995

Other funds holding GRI

ACM
Altium Capital Management New York $42M AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jim Simons's GRI Position: Q1 2024 in Review

Jim Simons sold out of GRI Bio (GRI) in Q1 2024, closing a stake of 1 share — an estimated $15K sold.

Jim Simons first reported a position in GRI in Q4 2023 and held it in 1 quarter. The position peaked at $15K in Q4 2023. 5 funds tracked by Wall St. Rank hold GRI as of Q1 2024.

  • Jim Simons reported no remaining GRI Bio position as of Q1 2024 after selling out during the quarter.
  • Jim Simons sold 1 GRI Bio share in Q1 2024, an estimated $15K.
  • Jim Simons first reported a position in GRI Bio in Q4 2023 and held it in 1 quarter.
  • Jim Simons's GRI Bio position peaked at $15K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held GRI Bio as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.